The chemical class known as MMP-13 Activators encompasses a diverse array of compounds that, while not directly interacting with the Matrix Metalloproteinase-13 (MMP-13) enzyme, play a crucial role in its regulation and activation through various indirect pathways. MMP-13, a member of the matrix metalloproteinases family, is primarily involved in the breakdown of collagen in extracellular matrix remodeling, a fundamental process in tissue repair and development. The activators of MMP-13 are characterized not by their direct binding to the enzyme, but by their influence on the cellular signaling pathways that govern MMP-13 expression and activity. These compounds, which include cytokines like TGF-β1, IL-1β, and TNF-α, growth factors such as EGF, PDGF, and FGF-2, and other agents like PMA, glucocorticoids, retinoic acid, vitamin D3, and LPS, operate through diverse mechanisms. They act by triggering specific cellular receptors and cascades, such as the SMAD, MAPK, NF-kB, EGFR, PDGFR, and TLR4 pathways, which ultimately lead to an upregulation or modulation of MMP-13 expression. This regulation can occur at multiple levels, from transcriptional to post-translational modifications, illustrating the complex network of interactions involved in MMP-13 activity control.
The study of MMP-13 activators is a dynamic field that underscores the intricate balance of cellular processes involved in matrix remodeling and collagen degradation. The complexity is further exemplified by the varied nature of these activators, each having a unique mode of action and a specific pathway through which it influences MMP-13. For instance, agents like PMA demonstrate the involvement of protein kinase C in MMP-13 regulation. This diversity not only reflects the multifunctional nature of MMP-13 in various physiological processes but also highlights the complex regulatory mechanisms that ensure its precise control in different cellular contexts. The study of these activators, therefore, provides essential insights into the sophisticated regulatory networks that govern MMP-13 activity and the broader implications of its modulation in tissue remodeling and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, leading to increased MMP-13 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates MMP-13 expression via retinoic acid receptors. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol influences MMP-13 activity by its receptor-mediated gene expression. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
Lipopolysaccharide (LPS) can induce MMP-13 expression in certain cell types via TLR4 signaling pathways. | ||||||